Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 516.50
+41.50 (8.74%)
Jul 10, 2026, 4:08 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 120.44 billion as of July 10, 2026. Its market cap has increased by 59.12% in one year.
Market Cap
120.44B
Enterprise Value
115.56B
Revenue
2.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
516.50
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 120.44B, an increase of 792.86%. That is a compound annual growth rate of 107.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 120.44B | 31.69% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.84B |
| Innovent Biologics | 155.92B |
| WuXi Biologics | 155.87B |
| Sino Biopharmaceutical | 92.53B |
| Akeso | 89.58B |
| RemeGen | 72.30B |
| Biocytogen Pharmaceuticals (Beijing) | 49.47B |
| 3SBio | 45.19B |